⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for anterior urethral cancer

Every month we try and update this database with for anterior urethral cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractNCT00014144
Bladder Cancer
Transitional Ce...
Urethral Cancer
gefitinib
- SWOG Cancer Research Network
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumNCT00082719
Bladder Cancer
Urethral Cancer
Recombinant Int...
- M.D. Anderson Cancer Center
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With ChemotherapyNCT00066612
Bladder Cancer
Transitional Ce...
Urethral Cancer
irinotecan hydr...
18 Years - SWOG Cancer Research Network
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumNCT00045630
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
gemcitabine
paclitaxel
surgery
18 Years - SWOG Cancer Research Network
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract CancerNCT01191892
Bladder Cancer
Transitional Ce...
Ureter Cancer
Urethral Cancer
carboplatin
gemcitabine hyd...
vandetanib
Placebo
18 Years - 120 YearsCardiff University
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumNCT00003376
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
cisplatin
doxorubicin hyd...
methotrexate
paclitaxel
vinblastine
18 Years - 120 YearsEastern Cooperative Oncology Group
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantNCT00082706
Bladder Cancer
Urethral Cancer
Urachal Cancer
5-Fluorouracil ...
Leucovorin
Cisplatin
Gemcitabine
18 Years - M.D. Anderson Cancer Center
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantNCT00082706
Bladder Cancer
Urethral Cancer
Urachal Cancer
5-Fluorouracil ...
Leucovorin
Cisplatin
Gemcitabine
18 Years - M.D. Anderson Cancer Center
Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)NCT01089088
Bladder Cancer
Transitional Ce...
Urethral Cancer
cisplatin
gemcitabine hyd...
sunitinib malat...
16 Years - 120 YearsCardiff University
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsNCT00900276
Bladder Cancer
Kidney Cancer
Transitional Ce...
Urethral Cancer
immunologic tec...
laboratory biom...
mass spectromet...
18 Years - 120 YearsWake Forest University Health Sciences
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractNCT00006351
Bladder Cancer
Transitional Ce...
Urethral Cancer
gemcitabine hyd...
lonafarnib
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the UrotheliumNCT00053209
Bladder Cancer
Transitional Ce...
Urethral Cancer
gemcitabine hyd...
pemetrexed diso...
18 Years - 120 YearsEastern Cooperative Oncology Group
Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumNCT00397488
Bladder Cancer
Transitional Ce...
Urethral Cancer
sunitinib malat...
18 Years - 120 YearsMemorial Sloan Kettering Cancer Center
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsNCT00253383
Cancer
counseling inte...
educational int...
psychosocial as...
quality-of-life...
18 Years - Dartmouth-Hitchcock Medical Center
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the UrotheliumNCT00045630
Bladder Cancer
Transitional Ce...
Urethral Cancer
carboplatin
gemcitabine
paclitaxel
surgery
18 Years - SWOG Cancer Research Network
Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractNCT00006026
Bladder Cancer
Transitional Ce...
Urethral Cancer
rubitecan
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractNCT00006111
Bladder Cancer
Transitional Ce...
Urethral Cancer
cisplatin
fluorouracil
conventional su...
radiation thera...
18 Years - 70 YearsUNICANCER
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractNCT00014144
Bladder Cancer
Transitional Ce...
Urethral Cancer
gefitinib
- SWOG Cancer Research Network
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerNCT01639521
Anterior Urethr...
Localized Trans...
Posterior Ureth...
Recurrent Bladd...
Recurrent Ureth...
Regional Transi...
Stage III Bladd...
Transitional Ce...
Ureter Cancer
Urethral Cancer...
cisplatin
gemcitabine hyd...
methotrexate
vinblastine
doxorubicin hyd...
pegfilgrastim
laboratory biom...
18 Years - University of Southern California
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: